Compare VCRE & AFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | VCRE | AFB |
|---|---|---|
| Founded | 2000 | 2001 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | | Trusts Except Educational Religious and Charitable |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 271.7M | 271.9M |
| IPO Year | 2026 | N/A |
| Metric | VCRE | AFB |
|---|---|---|
| Price | $9.14 | $9.42 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $29.03 | N/A |
| AVG Volume (30 Days) | 23.7K | ★ 171.2K |
| Earning Date | 11-05-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 3.60% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $101.29 | N/A |
| Revenue Next Year | $481.15 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.88 | $9.28 |
| 52 Week High | $14.01 | $11.50 |
| Indicator | VCRE | AFB |
|---|---|---|
| Relative Strength Index (RSI) | 42.39 | 34.03 |
| Support Level | $8.34 | $9.28 |
| Resistance Level | $12.08 | $11.14 |
| Average True Range (ATR) | 0.82 | 0.14 |
| MACD | 0.01 | 0.03 |
| Stochastic Oscillator | 30.58 | 20.69 |
Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.
Alliancebernstein National Muni Inc Fd is a diversified, closed-end management investment company. It seeks to provide high current income exempt from regular federal income tax by investing substantially all of its net assets in municipal securities that pay interest that is exempt from federal income tax.